期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinical Study on Ganbi Decoction (肝痹汤) in Treating Antituberculotic Agent-Caused Liver Injury 被引量:3
1
作者 线胤生 王作仁 +1 位作者 弓显风 黄保中 《Chinese Journal of Integrated Traditional and Western Medicine》 2006年第2期107-111,共5页
Objective: To study the effect and mechanism of Ganbi decoction (GBD, 肝痹汤 ) in treating patients with antituberculotic agent caused liver injury (ATB-LI). Methods: One hundred and twenty-eight patients with A... Objective: To study the effect and mechanism of Ganbi decoction (GBD, 肝痹汤 ) in treating patients with antituberculotic agent caused liver injury (ATB-LI). Methods: One hundred and twenty-eight patients with ATB-LI were randomly assigned to the treated group ( n = 66) and the control group ( n = 62) with the envelop method. Meanwhile, 60 healthy persons were selected as the healthy control group. The treated group was treated by GBD one dose every day with the constituents modified depending on patients' symp- toms, and the control group was treated with glucuronolactone tablets and inosine injection. One week was taken as one treatment course. The changes of clinical syndromes, physical signs, T-lymphycyte sub-groups and serum level of nitric oxide (NO) were observed before and after treatment and the recovery time of liver function was recorded. The outcome was compared with that in the healthy control group. Results: In the treated group, 28 patients (42.4%) were cured, 30 (45.5%) improved and 8 ( 12.1% ) ineffectively cured, the total effective rate being 87.9% (58/66). In the control group, 17 patients (27.4%) were cured, 24 (38.7%) improved, and21 (33.9%)ineffectively cured, the total effective rate being 66.1% (41/62). The total effective rate in the treated group was significantly higher than that in the control group ( P〈0. 05). Liver function was improved in both groups, recovery time in the treated group was 12.0±7.0 days, which was significantly shorter than that in the control group (16.0±8.0 days), showing significant difference between the two groups ( P〈0.05). The levels of CD3, CD4 and CD8 were significantly higher and level of NO significantly lower in the two groups of patients than those in the healthy control group ( P〈0. 05), but these parameters were improved more significantly in the treated group after treatment, when compared with those before treatment or with those in the control group, all showing 展开更多
关键词 ganbi Decoction anti-tuberculosis agent liver injury
下载PDF
肝痹汤治疗抗痨药后肝损害疗效观察 被引量:6
2
作者 弓显凤 蒲兰元 +1 位作者 缐胤生 黄保中 《中医杂志》 CSCD 北大核心 2000年第3期157-158,共2页
74例抗痨药后肝损害(药物性肝病)患者随机分为治疗组38例和对照组36例。治疗组用肝痹汤治疗;对照组口服肝泰乐、静脉点滴肌苷注射液治疗。分别观察治疗前后临床症状体征改善情况,肝功能恢复正常时间,及T淋巴细胞亚群指标。结果表明,治... 74例抗痨药后肝损害(药物性肝病)患者随机分为治疗组38例和对照组36例。治疗组用肝痹汤治疗;对照组口服肝泰乐、静脉点滴肌苷注射液治疗。分别观察治疗前后临床症状体征改善情况,肝功能恢复正常时间,及T淋巴细胞亚群指标。结果表明,治疗组各项实验室检查结果与对照组比较,差异均有显著性(P<0.05或P<0.01)。治疗组总有效率显著高于对照组(P<0.05)。 展开更多
关键词 肝疾病 中医药治疗 抗结核药 副作用 肝痹汤
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部